Please login. Quantitative information is available (for free) after you have agreed to the terms and conditions and disclaimers.

Johanna Bennett

Contributor to Barron's online.

More information: barron's articles

ASSESSMENT

Mixed   Abs   B'Mark
# Quants (Adj) 224.6 224.6 224.6
RAAER N/A N/A N/A
Excess AER N/A N/A N/A
P-Value N/A N/A N/A
[ ]
EVIDENCE
Page:  1 / 3
About US:MDCO Medicines Co.<br/><br/>Please login. Quantitative information is available (for free) after you have agreed to the terms and conditions and disclaimers., Johanna Bennett said: “The Medicines Co. Offers Investors 25% Upside ... FDA approval of a new antibiotic to treat acute skin infections should get the battered stock back on track.” in online.barrons.com$ on 7th Aug 2014 and 0 commented
Commentary
No opinions yet - be the first to add one!
About US:CVS CVS Caremark Corp.<br/><br/>Please login. Quantitative information is available (for free) after you have agreed to the terms and conditions and disclaimers., Johanna Bennett said: “With CVS Caremark's second-quarter results handily beating Street estimates, the stock remains a buy.” in online.barrons.com$ on 5th Aug 2014 and 1 commented
Commentary
About US:AMGN Amgen Inc.<br/><br/>Please login. Quantitative information is available (for free) after you have agreed to the terms and conditions and disclaimers., Johanna Bennett said: “Amgen Stock Can Gain 25% Amid Restructuring - Investors are cheering strong second-quarter results, an upbeat forecast and restructuring plan. Why shares could rise by 25%.” in online.barrons.com$ on 30th Jul 2014 and 0 commented
Commentary
No opinions yet - be the first to add one!
About US:AA Alcoa Inc.<br/><br/>Please login. Quantitative information is available (for free) after you have agreed to the terms and conditions and disclaimers., Johanna Bennett said: “With its purchase of Firth Rixson, expect Alcoa to rise further.” in online.barrons.com$ on 26th Jun 2014 and 0 commented
Commentary
No opinions yet - be the first to add one!
About US:MON Monsanto Co.<br/><br/>Please login. Quantitative information is available (for free) after you have agreed to the terms and conditions and disclaimers., Johanna Bennett said: “Monsanto Buyback Sets Stage for Higher Stock Price” in online.barrons.com$ on 25th Jun 2014 and 0 commented
Commentary
No opinions yet - be the first to add one!
About US:COH Coach Inc.<br/><br/>Please login. Quantitative information is available (for free) after you have agreed to the terms and conditions and disclaimers., Johanna Bennett said: “Coach's Clobbered Stock Looks Oversold - The luxury retailer is slashing estimates amid fierce competition. But with a 4% yield, shares may reward patient investors.” in online.barrons.com$ on 23rd Jun 2014 and 0 commented
Commentary
No opinions yet - be the first to add one!
About US:CELG Celgene Corp.<br/><br/>Please login. Quantitative information is available (for free) after you have agreed to the terms and conditions and disclaimers., Johanna Bennett said: “Celgene Lifted by Split, Buyback Has More Upside” in online.barrons.com$ on 19th Jun 2014 and 0 commented
Commentary
No opinions yet - be the first to add one!
About US:FDX FedEx Corp.<br/><br/>Please login. Quantitative information is available (for free) after you have agreed to the terms and conditions and disclaimers., Johanna Bennett said: “FedEx Stock Can Deliver More Upside to Investors - Better-than-expected quarterly results and a bullish forecast for the new fiscal year point to more gains.” in online.barrons.com$ on 18th Jun 2014 and 0 commented
Commentary
No opinions yet - be the first to add one!
About US:ULTA vs Equities (US)Ulta Salon Cosmetics & Fragrance Inc.<br/><br/>Please login. Quantitative information is available (for free) after you have agreed to the terms and conditions and disclaimers., Johanna Bennett said: “Investors should think twice about chasing Ulta Salon despite its strong earnings results.” in online.barrons.com$ on 11th Jun 2014 and 0 commented
Commentary
No opinions yet - be the first to add one!
About US:WLP WellPoint Inc<br/><br/>Please login. Quantitative information is available (for free) after you have agreed to the terms and conditions and disclaimers., Johanna Bennett said: “WellPoint: Unloved Insurer Could Rise at Least 20%. Investors feared Obamacare would hurt the company; instead its profits, and share price, are soaring.” in online.barrons.com$ on 4th Jun 2014 and 0 commented
Commentary
No opinions yet - be the first to add one!